Company Overview
Team Members
Technologies
Email Formats
Competitors
Faqs

10 free leads on us

Use our Chrome Extension & instantly connect with prospects

Download Free
Use Google
crystals

Find Contacts

Homepage  >  Manufacturing  > 

PhaseBio Pharmaceuticals

Company Name

PhaseBio Pharmaceuticals

Main Industry

Pharmaceuticals, Manufacturing

Website

www.phasebio.com

Contact Information

Malvern, Pennsylvania Office

1 Great Valley Pkwy Ste 30, Malvern, Pennsylvania, 19355, United States

(610) 981-6500

Malvern, Pa Office

1 Great Valley Pkwy Ste 30, Malvern, Pa, 19355, Brazil

San Diego, California Office

11260 El Camino Real Ste 100, San Diego, California, 92130, United States

(610) 981-6500

PhaseBio Pharmaceuticals Profile and History

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat cardiopulmonary diseases. The company's lead development candidate is PB2452, a novel reversal agent for the antiplatelet therapy ticagrelor. PhaseBio is also leveraging its proprietary elastin-like polypeptide ("ELP") technology platform to deve lop therapies with the potential for less-frequent dosing and improved pharmacokinetics. PhaseBio's second product candidate PB1046, which is based on ELP, is a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension.

...Read More

Phasebio Pharmaceuticals

Phasebio Pharmaceuticals Inc

Phase Bio

PhaseBio Publications

Phase Bioscience

Revenue

$10.9 M

Employees

60

Founded

2002

Funding History

PhaseBio Pharmaceuticals raised a total of $389.2 M in funding over 11 rounds, and is a public traded company.

Stock Symbol

NASDAQ: PHAS

PhaseBio Pharmaceuticals Executive Team & Key Decision Makers

Name & TitleContact Info
John-Paul Lee
John-Paul Lee

Chief Medical Officer

(215) ❅❅❅-❅❅❅❅

Visit Profile

Kyle Casement
Kyle Casement

Director, Finance & Corporate Controller

(760) ❅❅❅-❅❅❅❅

Visit Profile

Kris Hanson
Kris Hanson

Vice President & Head of Legal

❅❅❅❅@phasebio.com

(858) ❅❅❅-❅❅❅❅

Visit Profile

Susan Arnold
Susan Arnold

Senior VP, Technical Operations

❅❅❅❅@phasebio.com

(215) ❅❅❅-❅❅❅❅

Visit Profile

Glen Burkhardt
Glen Burkhardt

Senior VP, Human Resources

❅❅❅❅@phasebio.com

(650) ❅❅❅-❅❅❅❅

Visit Profile

Michael Reid
Michael Reid

Director, Quality Assurance & CMC

(484) ❅❅❅-❅❅❅❅

Visit Profile

Jeffrey Glenn
Jeffrey Glenn

Senior Director, Analytical Development

❅❅❅❅@phasebio.com

(240) ❅❅❅-❅❅❅❅

Visit Profile

Kim Sorbello
Kim Sorbello

Associate Director, Supply Chain

❅❅❅❅@phasebio.com

(610) ❅❅❅-❅❅❅❅

Visit Profile

Edmund Harrigan

(860) ❅❅❅-❅❅❅❅

Visit Profile

Sarah Cirillo
Sarah Cirillo

Associate Director, Regulatory Affairs

❅❅❅❅@phasebio.com

Visit Profile

Dave Dickerhoff
Dave Dickerhoff

Associate Director, Manufacturing Science & Technology

❅❅❅❅@phasebio.com

(610) ❅❅❅-❅❅❅❅

Visit Profile

Recently Updated Team Members

Name & TitleContact Info
Kris Hanson
Kris Hanson

Vice President & Head of Legal

❅❅❅❅@phasebio.com

(858) ❅❅❅-❅❅❅❅

Visit Profile

Gina Wildman
Gina Wildman

Senior Accountant

❅❅❅❅@phasebio.com

(610) ❅❅❅-❅❅❅❅

Visit Profile

Kim Sorbello
Kim Sorbello

Associate Director, Supply Chain

❅❅❅❅@phasebio.com

(610) ❅❅❅-❅❅❅❅

Visit Profile

Shawn Colden
Shawn Colden

Manager, Clinical Operations

❅❅❅❅@phasebio.com

(610) ❅❅❅-❅❅❅❅

Visit Profile

John Lee
John Lee

Chief Medical Officer

❅❅❅❅@phasebio.com

(215) ❅❅❅-❅❅❅❅

Visit Profile

Susan Arnold
Susan Arnold

Senior VP, Technical Operations

❅❅❅❅@phasebio.com

(215) ❅❅❅-❅❅❅❅

Visit Profile

Glen Burkhardt
Glen Burkhardt

Senior VP, Human Resources

❅❅❅❅@phasebio.com

(650) ❅❅❅-❅❅❅❅

Visit Profile

Bret Umstead
Bret Umstead

Senior Scientist

❅❅❅❅@phasebio.com

(215) ❅❅❅-❅❅❅❅

Visit Profile

Chris Guerin
Chris Guerin

Clinical Research Consultant

❅❅❅❅@phasebio.com

(480) ❅❅❅-❅❅❅❅

Visit Profile

Kaye Kugler
Kaye Kugler

Director, Marketing

❅❅❅❅@phasebio.com

(619) ❅❅❅-❅❅❅❅

Visit Profile

Jeffrey Erickson
Jeffrey Erickson

Senior Director, Corporate Development

❅❅❅❅@phasebio.com

(619) ❅❅❅-❅❅❅❅

Visit Profile

Andrew Powers
Andrew Powers

Trial File Master & Manager

❅❅❅❅@phasebio.com

(610) ❅❅❅-❅❅❅❅

Visit Profile

Gail Zanecosky
Gail Zanecosky

Controller

❅❅❅❅@phasebio.com

(610) ❅❅❅-❅❅❅❅

Visit Profile

Top PhaseBio Pharmaceuticals Integrations and Technologies

Here's a list of some of the top trending technologies and APIs used by PhaseBio Pharmaceuticals.

Web Analytics

(4 Technologies)

Web Content Management Systems

(3 Technologies)

Frameworks and Libraries

(3 Technologies)

Programming Languages

(3 Technologies)

Other Communication and Collaboration Software

(3 Technologies)

PhaseBio Pharmaceuticals Email Formats

ParameterSample EmailPercentage

PhaseBio Pharmaceuticals Top Competitors

CompanyEmployeesRevenueTop technologies
Visterra Inc

Visterra Inc

86$19.5 M
Alzheon Inc

Alzheon Inc

21$4.4 M
Cymabay Therapeutics Inc

Cymabay Therapeutics Inc

59$20.3 M
Applied Therapeutics

Applied Therapeutics

33$7.2 M
Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

71$15 M

What is PhaseBio Pharmaceuticals revenue?

PhaseBio Pharmaceuticals revenue is $10.9 M

How many employees does PhaseBio Pharmaceuticals have?

PhaseBio Pharmaceuticals has 60 employees

What are PhaseBio Pharmaceuticals’s primary industries?

PhaseBio Pharmaceuticals’s main industries are: Manufacturing, Pharmaceuticals

Who is PhaseBio Pharmaceuticals’s CEO?

PhaseBio Pharmaceuticals’s CEO is Jonathan Mow

What are some additional names or alternative spellings that users use while searching for PhaseBio Pharmaceuticals?

PhaseBio Pharmaceuticals appears in search results as Phasebio Pharmaceuticals, Phasebio Pharmaceuticals Inc, Phase BioPhaseBio Publications, Phase Bioscience...See More